Amyotrophic Lateral Sclerosis and Risk of Common Cancer: Mendelian Randomization Interrogation of Causality and Mediation.

IF 6.2 Q2 GENETICS & HEREDITY
Phenomics (Cham, Switzerland) Pub Date : 2025-01-26 eCollection Date: 2025-06-01 DOI:10.1007/s43657-024-00159-9
Xiaoxue Tan, Gaifen Liu, Xiangnan Li, Fan Zhong, Zhixi Su, Haijian Wang
{"title":"Amyotrophic Lateral Sclerosis and Risk of Common Cancer: Mendelian Randomization Interrogation of Causality and Mediation.","authors":"Xiaoxue Tan, Gaifen Liu, Xiangnan Li, Fan Zhong, Zhixi Su, Haijian Wang","doi":"10.1007/s43657-024-00159-9","DOIUrl":null,"url":null,"abstract":"<p><p>Compared with the well-documented inverse comorbidity of common neurodegenerative diseases with some types of cancer, the association of amyotrophic lateral sclerosis (ALS) with cancer was obscure. This Mendelian randomization (MR) analysis was aimed to appraise the causal relationship of ALS with cancer. Leveraging summary statistics of genome-wide association study (GWAS) for ALS, overall-cancer and nine types of site-specific common solid cancer including colorectal cancer (CRC) in populations of European (discovery and replication) and East Asian ancestry, we investigated the causal association of ALS with cancer using inverse-variance weighted (IVW) method and complementary sensitivity analyses. We performed MR-based mediation analysis to assess possible role of serum lipid traits such as hyperlipidemia, one shared risk factor of ALS and CRC, in their causal association. We found that genetically-predicted ALS was not associated with overall-cancer and other tested types of cancer, but was causally associated with reduced risk of CRC [odds ratio (OR) 0.84; 95% confidence interval (95% CI) 0.74-0.96; <i>p</i> = 0.011, OR 0.32; 95% CI 0.15-0.69; <i>p</i> = 0.004, in datasets of European (discovery) and East Asian ancestry respectively]. We observed absences of directional pleiotropy (MR Egger, intercept = -0.02 and -0.02, <i>p</i> = 0.49 and 0.60), instrumental outlier (MR-PRESSO, <i>p</i> = 0.95 and 0.84) or heterogeneity (Cochran <i>Q</i>, <i>p</i> = 0.95 and 0.82). Null reverse causality of CRC with ALS was found in either datasets. However, we found no evidence of the inverse association of ALS with CRC in either the replication (OR 0.99; 95% CI 0.93-1.06) or the combined European datasets (OR 0.92; 95% CI 0.79-1.09). Mediation analysis in European datasets suggested that hyperlipidemia may affect the risk of CRC via ALS in an indirect manner, with the measured mediation effect of hyperlipidemia on CRC being -0.02 (95% CI -0.04 to -0.002, <i>p</i> = 0.03). Our two-sample MR study in <i>trans</i>-ethnic populations uncovered that genetically proxied ALS may be causally associated with reduced risk of CRC, providing new insight into the inverse comorbidity and etiological causality of neurodegenerative disease and cancer.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s43657-024-00159-9.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"5 3","pages":"270-283"},"PeriodicalIF":6.2000,"publicationDate":"2025-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12390901/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phenomics (Cham, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s43657-024-00159-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Compared with the well-documented inverse comorbidity of common neurodegenerative diseases with some types of cancer, the association of amyotrophic lateral sclerosis (ALS) with cancer was obscure. This Mendelian randomization (MR) analysis was aimed to appraise the causal relationship of ALS with cancer. Leveraging summary statistics of genome-wide association study (GWAS) for ALS, overall-cancer and nine types of site-specific common solid cancer including colorectal cancer (CRC) in populations of European (discovery and replication) and East Asian ancestry, we investigated the causal association of ALS with cancer using inverse-variance weighted (IVW) method and complementary sensitivity analyses. We performed MR-based mediation analysis to assess possible role of serum lipid traits such as hyperlipidemia, one shared risk factor of ALS and CRC, in their causal association. We found that genetically-predicted ALS was not associated with overall-cancer and other tested types of cancer, but was causally associated with reduced risk of CRC [odds ratio (OR) 0.84; 95% confidence interval (95% CI) 0.74-0.96; p = 0.011, OR 0.32; 95% CI 0.15-0.69; p = 0.004, in datasets of European (discovery) and East Asian ancestry respectively]. We observed absences of directional pleiotropy (MR Egger, intercept = -0.02 and -0.02, p = 0.49 and 0.60), instrumental outlier (MR-PRESSO, p = 0.95 and 0.84) or heterogeneity (Cochran Q, p = 0.95 and 0.82). Null reverse causality of CRC with ALS was found in either datasets. However, we found no evidence of the inverse association of ALS with CRC in either the replication (OR 0.99; 95% CI 0.93-1.06) or the combined European datasets (OR 0.92; 95% CI 0.79-1.09). Mediation analysis in European datasets suggested that hyperlipidemia may affect the risk of CRC via ALS in an indirect manner, with the measured mediation effect of hyperlipidemia on CRC being -0.02 (95% CI -0.04 to -0.002, p = 0.03). Our two-sample MR study in trans-ethnic populations uncovered that genetically proxied ALS may be causally associated with reduced risk of CRC, providing new insight into the inverse comorbidity and etiological causality of neurodegenerative disease and cancer.

Supplementary information: The online version contains supplementary material available at 10.1007/s43657-024-00159-9.

肌萎缩性侧索硬化症与常见癌症的风险:因果关系和中介的孟德尔随机化质疑。
与文献记载的常见神经退行性疾病与某些类型癌症的反向共病相比,肌萎缩侧索硬化症(ALS)与癌症的关系尚不清楚。这项孟德尔随机化(MR)分析旨在评估ALS与癌症的因果关系。利用全基因组关联研究(GWAS)对欧洲(发现和复制)和东亚血统人群中ALS、整体癌症和9种位点特异性常见实体癌症(包括结直肠癌)的汇总统计数据,我们使用反方差加权(IVW)方法和互补敏感性分析来研究ALS与癌症的因果关系。我们进行了基于磁共振的中介分析,以评估血脂特征(如高脂血症)在其因果关系中的可能作用,高脂血症是ALS和CRC的一个共同危险因素。我们发现,基因预测的ALS与总体癌症和其他测试类型的癌症无关,但与CRC风险降低有因果关系[比值比(OR) 0.84;95%置信区间(95% CI) 0.74-0.96;p = 0.011, OR 0.32;95% ci 0.15-0.69;p = 0.004,分别在欧洲(发现)和东亚血统的数据集中]。我们观察到不存在方向性多效性(MR Egger,截距= -0.02和-0.02,p = 0.49和0.60)、工具异常值(MR- presso, p = 0.95和0.84)或异质性(Cochran Q, p = 0.95和0.82)。在两组数据中均未发现结直肠癌与ALS的反向因果关系。然而,我们在复制(OR 0.99; 95% CI 0.93-1.06)或欧洲联合数据集(OR 0.92; 95% CI 0.79-1.09)中均未发现ALS与CRC负相关的证据。欧洲数据集的中介分析表明,高脂血症可能以间接方式影响经ALS发生CRC的风险,测量到的高脂血症对CRC的中介效应为-0.02 (95% CI -0.04 ~ -0.002, p = 0.03)。我们在跨种族人群中进行的两样本MR研究发现,遗传代理的ALS可能与结直肠癌风险降低有因果关系,为神经退行性疾病和癌症的逆共病和病因因果关系提供了新的见解。补充信息:在线版本包含补充资料,下载地址:10.1007/s43657-024-00159-9。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信